1. Home
  2. UNFI vs TARS Comparison

UNFI vs TARS Comparison

Compare UNFI & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Natural Foods Inc.

UNFI

United Natural Foods Inc.

HOLD

Current Price

$49.84

Market Cap

3.1B

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$56.44

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNFI
TARS
Founded
1976
2016
Country
United States
United States
Employees
25600
N/A
Industry
Food Distributors
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
UNFI
TARS
Price
$49.84
$56.44
Analyst Decision
Hold
Buy
Analyst Count
7
6
Target Price
$44.71
$89.00
AVG Volume (30 Days)
576.9K
1.2M
Earning Date
06-09-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.21
EPS
0.78
N/A
Revenue
N/A
$451,360,000.00
Revenue This Year
$0.47
$56.43
Revenue Next Year
$2.18
$30.19
P/E Ratio
$62.33
N/A
Revenue Growth
N/A
146.71
52 Week Low
$24.88
$38.51
52 Week High
$57.02
$85.25

Technical Indicators

Market Signals
Indicator
UNFI
TARS
Relative Strength Index (RSI) 53.59 41.00
Support Level $48.17 N/A
Resistance Level $53.37 $67.14
Average True Range (ATR) 1.75 4.36
MACD 0.28 -0.82
Stochastic Oscillator 82.54 13.33

Price Performance

Historical Comparison
UNFI
TARS

About UNFI United Natural Foods Inc.

United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: